Management of malignant pleural effusion and ascites by a triple access multi perforated large diameter catheter port system

Abstract

Background: Pleural or peritoneal effusions (ascites) are frequent in terminal stage malignancies. Medical management may be hazardous.

Single Paracostal Approach to Thoracic Duct and Cisterna Chyli: Experimental Study and Case Series

“…Placement of a subcutaneous vascular access port, connected to a fenestrated pleural drain has been reported for management of chronic (malignant and other) pleural effusions in humans and animals . Instrumenting an animal with this simple device allows pain‐free, regular thoracic drainage via a percutaneous needle, on an outpatient basis.…”

“…After discussion with owners regarding current literature and lack of gold standard of treatment, 4 owners requested additional SPE, which was performed through a right‐sided fifth intercostal thoracotomy. Thoracic drainage catheters (Veterinary Thoracic Drainage Catheter, Smiths Medical, Dublin, OH) were placed in the first 3 dogs and the other 5 dogs, a pleural portal (The Companion Port, Norfolk Vet Products, Skokie IL) was used to facilitate postoperative thoracic evacuation, as this became standard practice at our clinics institutions during this period.…”

Malignant Melanoma Presenting as Bilateral Pleural Effusion

“…Treatment in metastatic malignant melanoma is mainly palliative. A case of treatment of bilateral pleural effusion along with ascites with a multi-perforated catheter in malignant melanoma has been reported [10]. Malignant pleural effusion is primarily treated with chemical pleurodesis due to limited life expectancy [11].…”

Inhibitory Effects of Dunning Rat Prostate Tumor Fluid on Proliferation of the Metastatic MAT-LyLu Cell Line

“…Tumor-related fluid accumulation can be seen in the benign or malign tumors of the central nervous system as peri-tumor cysts (Lonser et al, 2005;Baggenstos et al, 2007), inside the peritoneum in liver, stomach, ovary, colon, and pancreas tumors and in the pleural space in lung cancer, breast cancer, and lymphomas (Heldin et al, 2004;Lonser et al, 2004;Inan et al, 2008).…”